UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.


Connected patient care | UBC
UBC - August 19, 2016
Reimbursement challenges can cause lengthy delays in therapy initiation for patients taking complex specialty medications. UBC’s new suite of digital tools are breaking down barriers to access and improving speed to therapy for...
FDA guidance for rare diseases
Irene Pan, MSc, Senior Research Scientist - August 18, 2016
By definition, a rare disease affects less than 200,000 Americans.1 Currently, there exists an estimated 5000-8000 rare diseases affecting more than 25 million Americans.2 The lack of adequate understanding of the pathophysiology and...
Pharma Heroes charity | International Medical Corps | UBC
UBC - August 16, 2016
The Pharma Hero campaign seeks to celebrate the great work of our colleagues in the pharma and biotech industry. We also wanted to do a little good work of our own by making a charitable donation for each Pharma Hero nomination we...
HRU and Cost Analysis in EU-5
Erwin De Cock, Scientific Consultant - August 11, 2016
Databases are essential tools for pharmacoeconomic research. While North America has large administrative claims databases, hospital databases, and electronic medical record systems, databases in Europe are scarcer, integrated primary...
UBC supports patients with psoriasis
Michele Hay, RN, BSN, Nurse Clinician - August 09, 2016
Psoriasis affects more than 100 million people worldwide according to the World Health Organization. The number of triggers and associated comorbidities make this immune disorder difficult for patients to manage. As part of Psoriasis...